Selective Lasertrabeculoplasty and Ocular Hemodynamics in Glaucoma

Effect of Selective Lasertrabeculoplasty (SLT) on Ocular Hemodynamics in Glaucoma

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01363362

Acronym

SLT/OBF

Enrollment

150

Registered

2011-06-01

Start date

2010-12-31

Completion date

2011-08-31

Last updated

2012-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

Selective Laser Trabeculoplasty, pulsatile ocular blood flow

Brief summary

Selective Laser Trabeculoplasty (SLT) is known to reduce intraocular pressure in glaucoma patients. This study investigates, if there are changes in different ocular hemodynamic parameters prior and after SLT.

Detailed description

Ocular blood flow, ocular pulse amplitude and ocular pulse volume are measured with the Blood Flow Analyzer (Paradigm Medical Industries, Inc.) prior and 3 month after SLT.

Interventions

PROCEDURESelective Laser Trabeculoplasty

360° selective laser trabeculoplasty, 100 non-overlapping spots, energy 0,5-1,2 mJ

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* glaucoma patient * over 18 years * needs further intraocular pressure regulation

Exclusion criteria

* age under 18 years * debilitated * no glaucoma

Design outcomes

Primary

Measure	Time frame	Description
Change in ocular hemodynamics after Selective Laser Trabeculoplasty (SLT)	baseline and 3 month	Pulsatile ocular blood flow, ocular pulse amplitude and ocular pulse volume are measured prior and 3 month after SLT with the Blood Flow Analyzer (Paradigm Medical Industries, Inc.)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026